Glaucoma
Glaucoma is an eye disease that causes damage to nerve fibers and the optic nerve, leading to the loss of the visual field.
Several studies have shown that preserved glaucoma medication can lead to additional complaints, such as dry eyes.1 That is why we have unpreserved eye drops available for the treatment of glaucoma. These are intended to lower the eye pressure.
1 J.A.P. Gomes et al. / The Ocular Surface xxx (2017) 516-543, TFOS DEWS II iatrogenic report, P. 519, 4.2.1. Incidence and prevalence
Products
-
Lees meer: Bimatoprost
Bimatoprost
Bimatoprost Stulln 0.3 mg/ml is an unpreserved eye drop in a multidose bottle.
The therapeutic indication of Bimatoprost Stulln is reduction of increased intraocular pressure in chronic open
Angle glaucoma and ocular hypertension in adults (as monotherapy or as an adjunctive treatment with beta-blockers).Bimatoprost Stulln 0.3 mg/ml, an unpreserved eye drop in a multidose bottle.
-
Lees meer: Dorzolamide + Timolol
Dorzolamide + Timolol
Dorzolamide + Timolol Stulln without preservative contains two ingredients: dorzolamide and timolol. Dorzolamide belongs to a group of medicines called ‘carbonic anhydrase inhibitors’. Timolol belongs to a group of medicines called ‘beta blockers’. These ingredients both lower eye pressure in different ways.
This drug is prescribed to glaucoma patients who wish to lower eye pressure in the treatment of glaucoma, when using an eye drop containing a beta-blocker alone, is not enough.
